CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE
Clinical trials for CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE trials appear
Sign up with your email to follow new studies for CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cancer drug shield young transplant patients from a deadly complication?
Disease control OngoingThis study tests whether adding the drug vorinostat to standard care can prevent graft-versus-host disease (GVHD) in children, adolescents, and young adults receiving a bone marrow or blood stem cell transplant for blood cancers. Researchers are first finding the best dose of vor…
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New hope for leukemia patients: asciminib trial underway
Disease control OngoingThis phase 2 trial tests asciminib, a daily oral drug, in 34 adults with chronic myeloid leukemia. Some participants have already tried one other treatment, while others are newly diagnosed. The study aims to see if asciminib can reduce cancer cells to very low levels. Doses may …
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA - CHRONIC PHASE
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC